Tharimmune (THAR) Stock Chart & Stock Price History $1.25 -0.01 (-0.40%) As of 08/8/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Tharimmune Stock Price Performance The Tharimmune (THAR) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 58.73%, with a year-to-date return of -39.21%. In the past month, the stock has decreased 30.28%, reflecting recent market activity. As of the latest close, Tharimmune traded at $1.23 with a market cap of $5.21 million and volume of 6,256 shares. Receive THAR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tharimmune and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+1.15%1 Month Performance-30.28%3 Month Performance-18.28%Year-To-Date Performance-39.21%1 Year Performance-58.73% THAR Stock Chart for Sunday, August, 10, 2025 THAR Chart by TradingView Tharimmune Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/08/2025$1.26$1.23-2.06%$1.26$1.236,256 shs$5.21 million08/07/2025$1.21$1.26+4.13%$1.32$1.2218,033 shs$5.32 million08/06/2025$1.22$1.21-0.82%$1.26$1.2019,132 shs$5.11 million08/05/2025$1.33$1.22-8.27%$1.35$1.2081,302 shs$5.15 million08/04/2025$1.24$1.33+7.26%$1.36$1.2463,235 shs$5.61 million08/01/2025$1.25$1.24-0.72%$1.26$1.2117,180 shs$3.30 million07/31/2025$1.32$1.25-5.38%$1.32$1.2510,958 shs$3.32 million07/30/2025$1.34$1.32-1.49%$1.34$1.3137,369 shs$3.51 million07/29/2025$1.46$1.34-8.22%$1.47$1.3460,710 shs$3.56 million07/28/2025$1.49$1.46-2.28%$1.53$1.4614,404 shs$3.89 million Get the Latest News and Ratings for THAR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tharimmune and its competitors with MarketBeat's FREE daily newsletter. 07/25/2025$1.53$1.49-2.35%$1.54$1.4930,817 shs$3.98 million07/24/2025$1.66$1.53-7.83%$1.65$1.5035,893 shs$4.07 million07/23/2025$1.62$1.66+2.47%$1.66$1.6119,303 shs$4.42 million07/22/2025$1.66$1.62-2.64%$1.68$1.6210,013 shs$4.31 million07/21/2025$1.69$1.66-1.54%$1.70$1.6583,820 shs$4.43 million07/18/2025$1.65$1.69+2.42%$1.75$1.6770,254 shs$4.50 million07/17/2025$1.63$1.65+1.23%$1.74$1.6342,694 shs$4.39 million07/16/2025$1.68$1.63-2.98%$1.69$1.6145,535 shs$4.34 million07/15/2025$1.69$1.68-0.59%$1.82$1.60123,534 shs$4.47 million07/14/2025$1.73$1.69-2.31%$1.81$1.65109,430 shs$4.50 million07/11/2025$1.77$1.73-2.26%$1.80$1.7118,511 shs$4.60 million07/10/2025$1.76$1.77+0.57%$1.79$1.7024,034 shs$4.71 million07/09/2025$1.76$1.76$1.88$1.7314,131 shs$4.68 million Related Companies Dare Bioscience Stock Chart BioXcel Therapeutics Stock Chart Finch Therapeutics Group Stock Chart Relmada Therapeutics Stock Chart Moleculin Biotech Stock Chart Promis Neurosciences Stock Chart Chemomab Therapeutics Stock Chart NeuroSense Therapeutics Stock Chart Passage Bio Stock Chart Hoth Therapeutics Stock Chart Receive THAR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tharimmune and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:THAR) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredI trusted Trump and got screwedPorter Stansberry says he got one thing wrong—and now millions of Americans could pay the price. After warning...Porter & Company | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tharimmune, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tharimmune With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free THAR Stock Alerts